🇺🇸 FDA
Patent

US 6495582

Isoxazole compositions useful as inhibitors of ERK

expired A61PA61P1/00A61P1/02

Quick answer

US patent 6495582 (Isoxazole compositions useful as inhibitors of ERK) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/16, A61P1/18